1,108
Participants
Start Date
Not specified
Primary Completion Date
March 31, 2007
Study Completion Date
March 31, 2007
YM178
3 Sites, Antwerp
2 Sites, Brussels
Ghent
Leuven
Liège
Brno
Mělník
Ostrava
3 Sites, Prague
Ústí nad Labem
Zlín
Holbæk
Kolding
Roskilde
2 Sites, Nantes
2 Sites, Paris
Bad Ems
Bamberg
Bautzen
Berlin
Dresden
Frankfurt
Hagenow
Halle
Hamburg
Koblenz
Leipzig
München
Radebeul
Trier
Uetersen
3 Sites, Athens
Pátrai
Miskolc
Nyíregyháza
Pécs
Sopron
Szeged
Tatabánya
Catanzaro
Milan
Modena
Padua
Roma
Sassari
Torino
Udine
Varese
Amsterdam
Apeldoorn
Arnhem
Eindhoven
Enschede
Maastricht
Bergen
Oslo
Tønsberg
Bialystok
Katowice
Kielce
Lublin
3 Sites, Warsaw
3 Sites, Wroclaw
7 Sites, Moscow
3 Sites, Saint Petersburg
2 Sites, Barcelona
Bilbao
2 Sites, Madrid
Manacor
Miranda de Ebro
San Juan de Alica
Seville
Vigo
Gothenburg
2 Sites, Stockholm
Birmingham
Blackburn
Chichester
Croydon
London
Reading
Sheffield
Southampton
Swansea
Lead Sponsor
Astellas Pharma Europe B.V.
INDUSTRY
Astellas Pharma Inc
INDUSTRY